Spot Trading’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$2.33M Sell
36,605
-144,522
-80% -$8.44M 0.04% 641
2017
Q2
$10.1M Buy
181,127
+125,948
+228% +$6.85M 0.2% 75
2017
Q1
$3M Sell
55,179
-83,128
-60% -$4.56M 0.1% 201
2016
Q4
$8.08M Buy
138,307
+114,107
+472% +$6.24M 0.19% 106
2016
Q3
$1.3M Buy
+24,200
New +$1.55M 0.03% 894
2016
Q2
Sell
-2,459
Closed -$174K 3321
2016
Q1
$157K Buy
+2,459
New +$155K ﹤0.01% 2351
2015
Q4
Sell
-85,966
Closed -$5.68M 3617
2015
Q3
$5.09M Buy
85,966
+333
+0.4% +$21.1K 0.05% 506
2015
Q2
$5.7M Buy
+85,633
New +$5.64M 0.05% 492
2015
Q1
Sell
-8,456
Closed -$529K 3909
2014
Q4
$499K Sell
8,456
-53,394
-86% -$3.01M ﹤0.01% 2349
2014
Q3
$3.17M Sell
61,850
-6,516
-10% -$325K 0.02% 1224
2014
Q2
$3.32M Buy
68,366
+60,752
+798% +$2.99M 0.02% 1237
2014
Q1
$396K Sell
7,614
-61,136
-89% -$3.25M ﹤0.01% 2715
2013
Q4
$3.65M Buy
68,750
+36,736
+115% +$1.87M 0.02% 1098
2013
Q3
$1.48M Sell
32,014
-29,823
-48% -$1.31M 0.01% 1614
2013
Q2
$2.76M Buy
+61,837
New +$2.68M 0.02% 1125

Other funds holding BMY

Spot Trading's BMY Position: Q3 2017 in Review

Spot Trading reduced its Bristol-Myers Squibb (BMY) stake by 80% in Q3 2017, selling an estimated $8.44M and leaving 36,605 shares worth $2.33M. The position accounts for 0.04% of the portfolio, ranked #641.

Spot Trading first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $10.1M in Q2 2017. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Spot Trading held 36,605 shares of Bristol-Myers Squibb worth $2.33M as of Q3 2017.
  • Spot Trading sold 144,522 Bristol-Myers Squibb shares in Q3 2017, an estimated $8.44M.
  • Bristol-Myers Squibb made up 0.04% of Spot Trading's portfolio in Q3 2017, its #641 holding.
  • Spot Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
  • Spot Trading's Bristol-Myers Squibb position peaked at $10.1M in Q2 2017.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.